Differences in characteristics, health status and fulfillment of exercise recommendations between axial spondyloarthritis patients with and without supervised group exercise (2022)
https://pubmed.ncbi.nlm.nih.gov/35661547/

Baseline serum biomarkers of inflammation, bone turnover and adipokines predict spinal radiographic progression in ankylosing spondylitis patients on TNF inhibitor therapy (2022)
https://pubmed.ncbi.nlm.nih.gov/34128804/

Extraskeletal Manifestations in Axial Spondyloarthritis Are Associated With Worse Clinical Outcomes Despite the Use of Tumor Necrosis Factor Inhibitor Therapy (2022)
https://pubmed.ncbi.nlm.nih.gov/34393101/

B Cell Involvement in the Pathogenesis of Ankylosing Spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/34948121/

Efficacy of a tight-control and treat-to-target strategy in axial spondyloarthritis: results of the open-label, pragmatic, cluster-randomised TICOSPA trial (2021)
https://pubmed.ncbi.nlm.nih.gov/33958325/

Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/33492397/

The mSQUASH; a valid, reliable and responsive questionnaire for daily physical activity in patients with axial spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34144381/

CD27 – CD38 low CD21 low B-Cells Are Increased in Axial Spondyloarthritis (2021)
https://pubmed.ncbi.nlm.nih.gov/34168654/

Bone mineral density improves during 2 years of treatment with bisphosphonates in patients with ankylosing spondylitis (2021)
https://pubmed.ncbi.nlm.nih.gov/32530102/

The IMPACT study: A clustered randomized controlled trial to assess the effect of a referral algorithm for axial spondyloarthritis (2020)
https://pubmed.ncbi.nlm.nih.gov/31990912/

High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30624693/

High prevalence of hip involvement and decrease in inflammatory ultrasound lesions during tumour necrosis factor-α blocking therapy in ankylosing spondylitis (2019)
https://pubmed.ncbi.nlm.nih.gov/30624693/